ES2108138T3 - Matriz termocoloide controlada por la forma sol a base de gelatina para formas perorales de liberacion retardada. - Google Patents

Matriz termocoloide controlada por la forma sol a base de gelatina para formas perorales de liberacion retardada.

Info

Publication number
ES2108138T3
ES2108138T3 ES92924548T ES92924548T ES2108138T3 ES 2108138 T3 ES2108138 T3 ES 2108138T3 ES 92924548 T ES92924548 T ES 92924548T ES 92924548 T ES92924548 T ES 92924548T ES 2108138 T3 ES2108138 T3 ES 2108138T3
Authority
ES
Spain
Prior art keywords
peroral
thermocoloid
delayed release
release forms
based sol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92924548T
Other languages
English (en)
Inventor
Jens-Christian Wunderlich
Ursula Schick
Jurgen Werry
Jurgen Freidenreich
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alfatec Pharma GmbH
Original Assignee
Alfatec Pharma GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alfatec Pharma GmbH filed Critical Alfatec Pharma GmbH
Application granted granted Critical
Publication of ES2108138T3 publication Critical patent/ES2108138T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2063—Proteins, e.g. gelatin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Luminescent Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

UN MEDICAMENTO PERORAL CON LIBERACION DE SUSTANCIA ACTIVA CONTROLADA ESTA COMPUESTO DE UNA MATRIZ DE GELATINA QUE SE DISUELVE CONTINUAMENTE EN UN MEDIO ACUOSO POR ENCIMA DE 37 UN MEDICAMENTO DISTRIBUIDO CON ELLA. LA LIBERACION DEL MEDICAMENTO, QUE PUEDE SER FACIL O ESCASAMENTE SOLUBLE, LIPOFILICO O HIDROFILICO, ES VARIABLE EN TIEMPO Y PUEDE SER ACEPTADO DE ACUERDO CON EL MEDICAMENTO.
ES92924548T 1991-12-05 1992-12-04 Matriz termocoloide controlada por la forma sol a base de gelatina para formas perorales de liberacion retardada. Expired - Lifetime ES2108138T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4140192A DE4140192C2 (de) 1991-12-05 1991-12-05 Sol-gesteuerte Thermokolloidmatrix auf Gelatinebasis für perorale Retardformen

Publications (1)

Publication Number Publication Date
ES2108138T3 true ES2108138T3 (es) 1997-12-16

Family

ID=6446393

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92924548T Expired - Lifetime ES2108138T3 (es) 1991-12-05 1992-12-04 Matriz termocoloide controlada por la forma sol a base de gelatina para formas perorales de liberacion retardada.

Country Status (9)

Country Link
US (1) US6068854A (es)
EP (1) EP0615442B1 (es)
AT (1) ATE158177T1 (es)
AU (1) AU3080392A (es)
DE (2) DE4140192C2 (es)
DK (1) DK0615442T3 (es)
ES (1) ES2108138T3 (es)
GR (1) GR3025362T3 (es)
WO (1) WO1993010764A1 (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL143197A0 (en) 1998-11-20 2002-04-21 Rtp Pharma Inc Dispersible phospholipid stabilized microparticles
US6992172B1 (en) * 1999-11-12 2006-01-31 Fibrogen, Inc. Recombinant gelatins
FR2805462B1 (fr) * 2000-02-24 2003-08-15 Therabel Res Nouvelle forme galenique orale a liberation prolongee de la molsidomine
JP2001329183A (ja) * 2000-05-22 2001-11-27 Yuichi Mori ゲル化性組成物
EP1320362B1 (en) * 2000-09-20 2011-08-31 Jagotec AG Stabilised fibrate microparticles
US8586094B2 (en) * 2000-09-20 2013-11-19 Jagotec Ag Coated tablets
US6569454B2 (en) * 2001-02-27 2003-05-27 Minh Van Nguyen Simple tablet compression using gelatin
CA2477221A1 (en) * 2003-01-03 2004-07-29 Minh Nguyen Simple tablet compression using gelatin
SI2279729T1 (sl) * 2003-07-17 2016-10-28 Banner Life Sciences, LLC Pripravki z nadziranim sproščanjem
US8778395B2 (en) * 2005-08-11 2014-07-15 Andrx Labs, Llc Diltiazem controlled release formulation and method of manufacture
ES2349322T7 (es) 2006-03-29 2019-10-17 Wista Lab Ltd Sales de 3,7-diamino-10H-fenotiazina y su utilización
JPWO2008081590A1 (ja) * 2006-12-27 2010-04-30 富士フイルム株式会社 医療用組成物
EP1961414A1 (en) * 2007-02-21 2008-08-27 FUJIFILM Manufacturing Europe B.V. A controlled release composition comprising a recombinant gelatin
EP1961411A1 (en) * 2007-02-21 2008-08-27 FUJIFILM Manufacturing Europe B.V. A controlled release composition
ATE551364T1 (de) * 2007-02-21 2012-04-15 Fujifilm Mfg Europe Bv Nicht natürliche rekombinante gelatinen mit erweiterter funktionalität
CA2701075C (en) * 2007-10-03 2019-02-12 Wista Laboratories Ltd. Therapeutic use of diaminophenothiazines.
DE102007051059B4 (de) * 2007-10-18 2014-04-03 NMI Naturwissenschaftliches und Medizinisches Institut an der Universität Tübingen Bioverbundmaterial für die kontrollierte Freisetzung von Wirkstoffen
JP5898701B2 (ja) 2011-02-11 2016-04-13 ウィスタ ラボラトリーズ リミテッド フェノチアジンジアミニウム塩およびそれらの使用
AU2017216928B2 (en) 2016-02-11 2018-09-20 Gelpell Ag Oral solid cannabinoid formulations, methods for producing and using thereof

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2183053A (en) * 1936-12-03 1939-12-12 Atlantic Coast Fisheries Co Vitamin preparation and method of making same
US2756177A (en) * 1953-03-09 1956-07-24 Hoffmann La Roche Process for making fat-soluble vitamin active powder
DE1059624B (de) * 1954-11-11 1959-06-18 Dr Knut Jacobus Sundman Verfahren zur Herstellung von in einer Traegersubstanz dispergierten Arzneien in dosierter Form
US3247066A (en) * 1962-09-12 1966-04-19 Parke Davis & Co Controlled release dosage form containing water-swellable beadlet
US3312594A (en) * 1963-06-21 1967-04-04 Squibb & Sons Inc Longlasting troche
GB1144915A (en) * 1966-11-24 1969-03-12 Armour Pharma Improvements in or relating to pastille formulations
US3492397A (en) * 1967-04-07 1970-01-27 Warner Lambert Pharmaceutical Sustained release dosage in the pellet form and process thereof
DE2037947C3 (de) * 1969-08-01 1983-01-13 Bush Boake Allen Ltd., London Eingekapselte Zubereitungen
US4107288A (en) * 1974-09-18 1978-08-15 Pharmaceutical Society Of Victoria Injectable compositions, nanoparticles useful therein, and process of manufacturing same
GB8514090D0 (en) * 1985-06-04 1985-07-10 Sandoz Ltd Organic compounds
EP0138216B1 (en) * 1983-10-14 1993-01-07 Sumitomo Pharmaceuticals Company, Limited Sustained-release ifn preparation for parenteral administration
WO1985005029A1 (en) * 1984-05-09 1985-11-21 Medaphore Inc. Oral insulin and a method of making the same
US4851392A (en) * 1985-02-05 1989-07-25 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US5011692A (en) * 1985-12-28 1991-04-30 Sumitomo Pharmaceuticals Company, Limited Sustained pulsewise release pharmaceutical preparation
GB8601204D0 (en) * 1986-01-18 1986-02-19 Boots Co Plc Therapeutic agents
IT1204294B (it) * 1986-03-11 1989-03-01 Gentili Ist Spa Metodo di fabbricazione di granulari atti a produzione di compresse rivestite,per uso orale,a rilascio controllato
CA1324083C (en) * 1987-03-09 1993-11-09 Tetsu Miyoshi Pharmaceutical preparations containing non-steroidal anti-inflammatory agents
GB8723846D0 (en) * 1987-10-10 1987-11-11 Danbiosyst Ltd Bioadhesive microsphere drug delivery system
SE8705136D0 (sv) * 1987-12-22 1987-12-22 Pharmacia Ab Oral doseringsenhet for lekemedel och dess anvendning och framstellning
DK546289D0 (da) * 1989-11-02 1989-11-02 Danochemo As Carotenoidpulvere
US5215756A (en) * 1989-12-22 1993-06-01 Gole Dilip J Preparation of pharmaceutical and other matrix systems by solid-state dissolution
US5126151A (en) * 1991-01-24 1992-06-30 Warner-Lambert Company Encapsulation matrix

Also Published As

Publication number Publication date
DE4140192A1 (de) 1993-06-09
DE4140192C2 (de) 1996-02-29
EP0615442A1 (de) 1994-09-21
ATE158177T1 (de) 1997-10-15
DK0615442T3 (da) 1997-10-20
US6068854A (en) 2000-05-30
EP0615442B1 (de) 1997-09-17
WO1993010764A1 (de) 1993-06-10
GR3025362T3 (en) 1998-02-27
DE59208919D1 (en) 1997-10-23
AU3080392A (en) 1993-06-28

Similar Documents

Publication Publication Date Title
ES2108138T3 (es) Matriz termocoloide controlada por la forma sol a base de gelatina para formas perorales de liberacion retardada.
ATE68969T1 (de) Im magen verbleibende granula.
ES2111547T3 (es) Comprimido de liberacion prolongada.
FR2542998B1 (fr) Nouvelle forme transdermale du dinitrate d'isosorbide
SE8803087D0 (sv) A new method of treating erectile dysfunction
ES2128370T3 (es) Composiciones que cambian de color.
ES516375A0 (es) Procedimiento para la obtencion de una composicion a base de estireno para revestir alimentos y medicamentos.
PT86536A (pt) Sistema terapeutico para ingredientes activos pouco soluveis
ES509647A0 (es) Procedimiento para preparar una polilactida.
ES2036457A1 (es) Forma de dosificacion farmaceutica solida oral de liberacion programada y procedimiento de preparacion.
AR242711A1 (es) Pelicula laminada bicomponente, el proceso para obtenerla y el articulo absorbente desechable que la incluye.
ES2042700T3 (es) Composiciones farmaceuticas con liberacion controlada, y metodo para su preparacion.
IS4675A (is) Örþeytur til að nota sem burðarefni við inngjöf virkra efna
DE3775973D1 (de) In gelatine eingekapselte zusammensetzung mit kontrollierter freisetzung.
MX9306993A (es) Uso de modificadores de turbidez no ionicos para minimizar la aglomeracionde nanoparticulas durante la esterilizacion.
BRPI9911849B8 (pt) composição espumante para a lavagem e o tratamento dos cabelos e/ou do couro cabeludo.
MX20055A (es) Procedimiento para la preparacion de una composicion acuosa de ibuprofen y procedimiento para su preparacion.
DE69123795D1 (de) Pharmazeutische Zusammensetzung zur rektalen Verabreichung von Wirkstoffen mit topischer medizinischer Wirkung im Dickdarmniveau
JPS51148013A (en) Stable insulin preparation for nosal administration
ATE217791T1 (de) Zur bildung einer mikroemulsion fähigen zusammensetzung mit verlängerter freisetzung des wirkstoffs
DE69117541D1 (de) Implantat mit durchgangsöffnung
ATE104554T1 (de) Topische praeparate.
ES2092559T3 (es) Formulacion farmaceutica que contiene penciclovir.
JPS5583710A (en) Spongy enzyme preparation
Restifo The comparative morphology of the penis in the Libellulid genera Celithemis, Leucorrhinia, and Libellula (Odonata)

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 615442

Country of ref document: ES